COSCIENS Biopharma Inc. Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset
COSCIENS Biopharma Inc. (CSCIF) reported Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset of $1.96 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Income Statement › Other Income
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset · last filed 2026-03-25
- COSCIENS Biopharma Inc. gain loss on remeasurement of net defined benefit liability asset for the quarter ending 2025-12-31 was $723.00K.
- COSCIENS Biopharma Inc. gain loss on remeasurement of net defined benefit liability asset for the quarter ending 2025-09-30 was -$2.00K.
- COSCIENS Biopharma Inc. gain loss on remeasurement of net defined benefit liability asset for the quarter ending 2025-06-30 was $129.00K.
- COSCIENS Biopharma Inc. gain loss on remeasurement of net defined benefit liability asset for the quarter ending 2025-03-31 was $1.11M, a 247.96% increase year-over-year.
| Period end | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 3 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 6 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 9 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $723.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $721.00K derived: sum of 2 quarters · filed 2026-03-25 | $850.00K derived: sum of 3 quarters · filed 2026-03-25 | $1.96M 20-F · filed 2026-03-25 | |
| 2025-09-30 | -$2.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $127.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.24M 6-K · filed 2025-11-12 | $1.02M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2025-06-30 | $129.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-14 | $1.24M 6-K · filed 2025-08-14 | $1.02M derived: sum of 3 quarters · filed 2026-03-25 | ||
| 2025-03-31 | $1.11M 6-K · filed 2025-05-13 | $889.00K derived: sum of 2 quarters · filed 2026-03-25 | |||
| 2024-12-31 | -$221.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$1.16M 20-F · filed 2026-03-25 | |||
| 2024-09-30 | -$936.00K 6-K · filed 2024-11-12 | ||||
| 2024-03-31 | $319.00K 6-K · filed 2024-05-16 | -$1.79M derived: sum of 2 quarters · filed 2024-07-17 | -$796.00K derived: sum of 3 quarters · filed 2024-07-17 | -$714.00K derived: sum of 4 quarters · filed 2024-07-17 | |
| 2023-12-31 | -$2.11M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$1.11M derived: sum of 2 quarters · filed 2024-07-17 | -$1.03M derived: sum of 3 quarters · filed 2024-07-17 | -$1.20M 20-F/A · filed 2024-07-17 | |
| 2023-09-30 | $993.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-09 | $1.07M derived: sum of 2 quarters · filed 2023-11-09 | $913.00K 6-K · filed 2023-11-09 | $14.10M derived: sum of 4 quarters · filed 2024-07-17 | |
| 2023-06-30 | $82.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-09 | -$80.00K 6-K · filed 2023-08-09 | $13.10M derived: sum of 3 quarters · filed 2024-07-17 | $14.41M derived: sum of 4 quarters · filed 2024-07-17 | |
| 2023-03-31 | -$162.00K 6-K · filed 2023-05-09 | $13.02M derived: sum of 2 quarters · filed 2024-07-17 | $14.33M derived: sum of 3 quarters · filed 2024-07-17 | $8.18M derived: sum of 4 quarters · filed 2024-07-17 | |
| 2022-12-31 | $13.18M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $14.49M derived: sum of 2 quarters · filed 2024-07-17 | $8.34M derived: sum of 3 quarters · filed 2024-07-17 | $5.26M 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $1.31M derived: 6-K 9 month − 6-K/A 6 month · filed 2022-11-03 | -$4.84M derived: sum of 2 quarters · filed 2022-11-03 | -$7.92M 6-K · filed 2022-11-03 | ||
| 2022-06-30 | -$6.15M derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | -$9.23M 6-K/A · filed 2022-08-04 | |||
| 2022-03-31 | -$3.08M 6-K · filed 2022-05-11 | ||||
| 2021-12-31 | -$3.59M 20-F/A · filed 2024-02-15 | $2.41M 6-K · filed 2022-05-11 | |||
| 2019-09-30 | -$536.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | -$2.03M 6-K · filed 2019-11-07 | |||
| 2019-06-30 | -$1.49M 6-K · filed 2019-08-13 | ||||
| 2018-12-31 | -$846.00K 6-K · filed 2019-11-07 | -$4.08M 20-F · filed 2019-04-01 | |||
| 2017-12-31 | -$4.28M 20-F · filed 2019-04-01 | ||||
| 2016-12-31 | -$4.97M 20-F · filed 2019-04-01 | ||||
| 2015-12-31 | -$3.49M 20-F · filed 2018-03-28 |